| Literature DB >> 30237656 |
Christina Pacheco1, Stela Mirla da Silva Felipe1, Milca Magalhães Dias de Carvalho Soares1, Juliana Osório Alves1, Paula Matias Soares1, José Henrique Leal-Cardoso1, Adriano César Carneiro Loureiro1, Alex Soares Marreiros Ferraz2, Denise Pires de Carvalho3, Vânia Marilande Ceccatto1.
Abstract
Regular exercise is an exogenous factor of gene regulation with numerous health benefits. The study aimed to evaluate human genes linked to physical exercise in an 'omic scale, addressing biological questions to the generated database. Three literature databases were searched with the terms 'exercise', 'fitness', 'physical activity', 'genetics' and 'gene expression'. For additional references, papers were scrutinized and a text-mining tool was used. Papers linking genes to exercise in humans through microarray, RNA-Seq, RT-PCR and genotyping studies were included. Genes were extracted from the collected literature, together with information on exercise protocol, experimental design, gender, age, number of individuals, analytical method, fold change and statistical data. The 'omic scale dataset was characterized and evaluated with bioinformatics tools searching for gene expression patterns, functional meaning and gene clusters. As a result, a physical exercise-related human gene compendium was created, with data from 58 scientific papers and 5.147 genes functionally correlated with 17 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. While 50.9% of the gene set was up-regulated, 41.9% was down-regulated. 743 up- and 530 down-regulated clusters were found, some connected by regulatory networks. To summarize, up- and down-regulation was encountered, with a wide genomic distribution of the gene set and up- and down-regulated clusters possibly assembled by functional gene evolution. Physical exercise elicits a widespread response in gene expression.Entities:
Keywords: Exercise gene ontology; Exercise genomics; Genes linked to physical exercise; Molecular exercise physiology; Physical exercise transcriptome
Year: 2017 PMID: 30237656 PMCID: PMC6135974 DOI: 10.5114/biolsport.2018.70746
Source DB: PubMed Journal: Biol Sport ISSN: 0860-021X Impact factor: 2.806
FIG. 1Study pipeline.
FIG. 2Summary of systematic review results
Physical exercise literature used for FitC characterization: exercise protocol, experimental design and sex of participants.
| Category | Characteristic | Number of genes |
|---|---|---|
| Exercise protocol | Endurance | 4497 |
| Exercise experimental design | Chronic | 4128 |
| Sex | Males | 583 |
FIG. 3Location of human genes related to exercise. In brackets are the numbers of Fitnome genes in each chromosome. The mitochondrial genome (Mt) is depicted in the upper portion of the figure. Different shades represent gene expression data.
Functional classification of FitC pathways. Metabolic pathways placed in hierarchical levels with statistical coverage and percentage of FitC genes in the KEGG pathways (KPs). Expression level is expressed as percentage of up-regulated (↑), down-regulated (↓) and genes with up- and down-regulation (↕).
| 1st hierarchical KEGG level | 2nd hierarchical KEGG level | KEGG Pathway (pathway ID) | Fisher test q-value | % of pathway genes | % Up/Down expression |
|---|---|---|---|---|---|
| Amino acid metabolism | Valine, leucine and isoleucine degradation (hsa00280) | 1.8X10-6 | 70 | ↑81 | |
| Arginine and proline metabolism (hsa00330) | 8.6 X10-3 | 52 | ↑56 | ||
| Carbohydrate metabolism | Citrate cycle (TCA cycle) (hsa00020) | 1.6 X10-4 | 70 | ↑100 | |
| Propanoate metabolism (hsa00640) | 2.4 X10-3 | 63 | ↑75 | ||
| Pyruvate metabolism (hsa00620) | 4.4 X10-2 | 50 | ↑80 | ||
| Energy metabolism | Oxidative phosphorylation (hsa00190) | 3.9 X10-16 | 68 | ↑92 | |
| Lipid metabolism | Fatty acid metabolism (hsa00071) | 2.4 X10-3 | 59 | ↑63 | |
| Circulatory system | Cardiac muscle contraction (hsa04260) | 1.7 X10-7 | 64 | ↑66 | |
| Endocrine system | PPAR signaling pathway (hsa03320) | 1.3 X10-4 | 57 | ↑44 | |
| Cardiovascular diseases | Viral myocarditis (hsa05416) | 8.5 X10-5 | 57 | ↑65 | |
| Hypertrophic cardiomyopathy (hsa05410) | 8.5 X10-5 | 55 | ↑49 | ||
| Immune diseases | Allograft rejection (has05330) | 1.8 X10-2 | 54 | ↑55 | |
| Neurodegenerative diseases | Parkinson’s disease (hsa05012) | 1.6 X10-17 | 70 | ↑86 | |
| Alzheimer’s disease (hsa05010) | 3.9 X10-16 | 64 | ↑79 | ||
| Huntington’s disease (hsa05016) | 1.9 X10-15 | 61 | ↑78 | ||
| Signal transduction | mTOR signaling pathway (hsa04150) | 1.4 X10-4 | 61 | ↑19 | |
| Notch signaling pathway (hsa04330) | 1.9 X10-2 | 51 | ↑54 |